NCT04608448View on ClinicalTrials.gov

Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

April 15, 2022

Study Completion Date

April 15, 2022

Conditions
AgingEpigeneticsInflammatory Mediators
Interventions
DRUG

Rapamycin Topical Ointment

8% topical rapamycin ointment

OTHER

Placebo

Petrolatum ointment containing no active ingredient

Trial Locations (1)

78220

UTHSCSA, San Antonio

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER